Wednesday, November 19, 2008

Regulatory Affairs :Recession Resistant

Clinical research organizations seems to be far away from global crunch as there is no near term impact of recession as major customers such as astrazeneca and glaxo continue to outsource more work to India.so India is getting more offshore work related to regulatory compliance and regulatory filing at one-fifth the US cost.

The $200-million regulatory affairs related Indian clinical research outsourcing market will escalate to $600 million by 2010,according to joint study done by research firm KPMG & CII.

India is the best destination for conducting global clinical trials because of faster enrollments,faster regulatory filings,speed up regulatory procedures.Eventually more man power is needed,so as to be at par with the increasing demand in this sector.Biopharmaceuticals companies are the key players with many major projects relating to regulatory clinical trials in pipeline.

Major players such as Biocon continue to get tremendous offshore work relating to regulatory clinical projects .”There is possibility that the global meltdown could mean a substantial increase in the revenues thus generated over the next few years.

2 comments:

Jayshri said...

Dear Varun

I m candidate of Pharma Drug Regulatory Affairs.
Its Kindly request to you,please guild me to complete my project of research study
I m very thankful to you if you give me your email id so that i can mail you if i have any doubt.

Awaiting your prompt reply.

Jayshri

varun said...

Dear Jayshiri

If you can mention your choice of topics in which you are intersted,we will assist you in completing research study but the research study assigned to you should be written by you.

Varun
m83.varun@gmail.com

Latest Pharma - Biotech Jobs

Latest Intellectual Property Jobs

Latest Biotechnology Jobs

BII Blog helps in dissemination of information and knowledge